172 related articles for article (PubMed ID: 8314771)
1. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.
Strongin AY; Marmer BL; Grant GA; Goldberg GI
J Biol Chem; 1993 Jul; 268(19):14033-9. PubMed ID: 8314771
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.
Strongin AY; Collier I; Bannikov G; Marmer BL; Grant GA; Goldberg GI
J Biol Chem; 1995 Mar; 270(10):5331-8. PubMed ID: 7890645
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
[TBL] [Abstract][Full Text] [Related]
4. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.
Goldberg GI; Strongin A; Collier IE; Genrich LT; Marmer BL
J Biol Chem; 1992 Mar; 267(7):4583-91. PubMed ID: 1311314
[TBL] [Abstract][Full Text] [Related]
5. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2.
DeClerck YA; Yean TD; Lu HS; Ting J; Langley KE
J Biol Chem; 1991 Feb; 266(6):3893-9. PubMed ID: 1847392
[TBL] [Abstract][Full Text] [Related]
7. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex.
Brown PD; Kleiner DE; Unsworth EJ; Stetler-Stevenson WG
Kidney Int; 1993 Jan; 43(1):163-70. PubMed ID: 8433556
[TBL] [Abstract][Full Text] [Related]
8. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
[TBL] [Abstract][Full Text] [Related]
9. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.
Goldberg GI; Marmer BL; Grant GA; Eisen AZ; Wilhelm S; He CS
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8207-11. PubMed ID: 2554304
[TBL] [Abstract][Full Text] [Related]
10. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.
Knäuper V; Cowell S; Smith B; López-Otin C; O'Shea M; Morris H; Zardi L; Murphy G
J Biol Chem; 1997 Mar; 272(12):7608-16. PubMed ID: 9065415
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of human collagenase-3.
Knäuper V; López-Otin C; Smith B; Knight G; Murphy G
J Biol Chem; 1996 Jan; 271(3):1544-50. PubMed ID: 8576151
[TBL] [Abstract][Full Text] [Related]
12. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.
Wilhelm SM; Collier IE; Marmer BL; Eisen AZ; Grant GA; Goldberg GI
J Biol Chem; 1989 Oct; 264(29):17213-21. PubMed ID: 2551898
[TBL] [Abstract][Full Text] [Related]
13. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
Shapiro SD; Fliszar CJ; Broekelmann TJ; Mecham RP; Senior RM; Welgus HG
J Biol Chem; 1995 Mar; 270(11):6351-6. PubMed ID: 7890773
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
[TBL] [Abstract][Full Text] [Related]
15. Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2).
Kleiner DE; Tuuttila A; Tryggvason K; Stetler-Stevenson WG
Biochemistry; 1993 Feb; 32(6):1583-92. PubMed ID: 8431437
[TBL] [Abstract][Full Text] [Related]
16. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
Stetler-Stevenson WG; Krutzsch HC; Liotta LA
Matrix Suppl; 1992; 1():299-306. PubMed ID: 1480041
[TBL] [Abstract][Full Text] [Related]
17. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor.
Kolkenbrock H; Orgel D; Hecker-Kia A; Noack W; Ulbrich N
Eur J Biochem; 1991 Jun; 198(3):775-81. PubMed ID: 1646720
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2.
Howard EW; Bullen EC; Banda MJ
J Biol Chem; 1991 Jul; 266(20):13064-9. PubMed ID: 2071592
[TBL] [Abstract][Full Text] [Related]
19. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.
Ward RV; Hembry RM; Reynolds JJ; Murphy G
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113
[TBL] [Abstract][Full Text] [Related]
20. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.
Stetler-Stevenson WG; Krutzsch HC; Wacher MP; Margulies IM; Liotta LA
J Biol Chem; 1989 Jan; 264(3):1353-6. PubMed ID: 2536363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
